This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Japan's top 4 pharma wholesalers raided by JFTC and Tokyo prosecutors for suspected criminal bid rigging

By Toko Sekiguchi ( October 13, 2020, 06:03 GMT | Insight) -- Japan’s top four pharmaceutical wholesalers Alfresa, Mediceo, Suzuken and Toho Pharmaceuticals were targets of a joint raid by antitrust authorities and prosecutors today on suspicions of rigging bids for drugs over a period of four years involving 140 billion yen (US $1.3 billion) and 57 hospitals, MLex has learned. The case is the first criminal antitrust probe since the 2017 investigation into the country’s top construction companies suspected of bid rigging on a national railway project.Japan’s top four pharmaceutical wholesalers Alfresa, Mediceo, Suzuken and Toho Pharmaceuticals were targets of a joint raid by antitrust authorities and prosecutors today on suspicions of rigging bids for drugs over a period of four years involving 140 billion yen (US $1.3 billion) and 57 hospitals, MLex has learned....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections